Procter & Gamble Health Limited (PGHL.BO)

INR 5064.8

(-0.15%)

Market Cap (In INR)

84.07 Billion

Revenue (In INR)

11.51 Billion

Net Income (In INR)

2 Billion

Avg. Volume

420.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
4640.3-5835.95
PE
35.53
EPS
142.54
Beta Value
0.508
ISIN
INE199A01012
CUSIP
-
CIK
-
Shares
16595139.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Milind Vasant Thatte M.B.A.
Employee Count
-
Website
https://www.pghealthindia.com
Ipo Date
2000-05-25
Details
Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.